Skip to main content

Press releases | July 27, 2021

Fried Frank acted as counsel to Becton, Dickinson and Company (BD) in its acquisition of Tepha, Inc. BD is a multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents. Tepha is a medical device company engaged in the development of medical device products that restore, maintain, or improvise tissue function. Tepha uses its expertise in biotechnology to produce absorbable biomaterials with properties tailored to various medical applications.

The Fried Frank team was led by partner Steven Epstein.


This communication is for general information only. It is not intended, nor should it be relied upon, as legal advice. In some jurisdictions, this may be considered attorney advertising. Please refer to the firm’s data policy page for further information.